QuestCap EV/EBIT
Qual é o EV/EBIT de QuestCap?
O EV/EBIT de QuestCap Inc. é 0.28
Qual é a definição de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de empresas na Setor Finance em OTC em comparação com QuestCap
O que QuestCap faz?
Medivolve Inc. is a principal investment firm. It is a social-impact investment focused company Investing resources, funds and bandwidth for the betterment of the human condition through medical sciences, climate change and technology. The firm was formerly known as Continent Resources Inc. and changed its name to Copper One Inc. in October 2009. Copper One Inc. was incorporated in 2005 and is headquartered in Toronto, Canada.
Empresas com ev/ebit semelhantes a QuestCap
- Noble plc tem EV/EBIT de 0.26
- Enwell plc tem EV/EBIT de 0.26
- Homology Medicines Inc tem EV/EBIT de 0.26
- Immunic tem EV/EBIT de 0.27
- Sage Therapeutics Inc tem EV/EBIT de 0.27
- Novacyt S.A tem EV/EBIT de 0.27
- QuestCap tem EV/EBIT de 0.28
- Oncternal Therapeutics tem EV/EBIT de 0.28
- Sulliden Mining Capital tem EV/EBIT de 0.29
- J4 Ventures tem EV/EBIT de 0.29
- Sulliden Mining Capital tem EV/EBIT de 0.30
- Bio-Path Inc tem EV/EBIT de 0.31
- Freeline Therapeutics plc tem EV/EBIT de 0.31